Industry Program

Tuesday 7 August
Medtronic Pre-conference Workshop

ACUTE STROKE MANAGEMENT WORKSHOP
Date
: Tuesday 7 August
Time: 0900-1230
Room: E3.9, Level 3, ICC (located in Exhibition building)
Cost: Included for all full conference delegates and day-only delegates
Speakers: 
  • Professor Chris Levi
  • Jenni Pedlar (Acute stroke advisor, models of care, NSW Ambulance Service)
  • Andrew Cheung (Interventional Neuroradiologist, Prince of Wales Hospital)
  • Sarah Kuhle (Project Officer, Statewide stroke clinical network, healthcare improvement unit and Queensland Health)
Description: This workshop will follow the pathway of an acute stroke patient from stroke onset to treatment and return to home. Each presenter will discuss their role in managing the patient and barriers that currently exist to being able to treat more patients. Topics include overview of stroke management, ambulance assessment and transfer, ED assessment and management, acute stroke imaging, thrombolysis, endovascular clot retrieval and discharge and return to home planning.
Bristol-Myers Squibb/Pfizer Pre-conference Workshop

RHYTHM & MALADY: WHAT YOU NEED TO KNOW ABOUT ADVANCES IN TREATMENT AND INTEGRATED CARE IN STROKE PREVENTION ACCORDING TO THE NEW AUSTRALIAN AF GUIDELINES
Date: Tuesday 7 August
Time: 1330-1700
Room: E3.9, Level 3, ICC (located in Exhibition building)
Cost: Included for all full conference delegates and day-only delegates
Speakers: 
  • Dr Darshan Ghia – Consultant Neurologist, Head of Stroke, Fiona Stanley Hospital, WA
  • Dr Jeroen Hendriks – Derek Frewin Lecturer, Centre for Heart Rhythm Disorders at the University of Adelaide and Royal Adelaide Hospital, SA
  • Prof Vincent Thijs – Consultant Neurologist, Head of Stroke, Austin Health, VIC
  • Dr Swati Mukherjee – Consultant Cardiologist, Cabrini Health, VIC
Description: Join a multidisciplinary team of experts in an interactive workshop as we discuss cutting-edge developments in stroke prevention and atrial fibrillation management in relation to the new 2018 Cardiac Society of Australia and New Zealand / Heart Foundation of Australia AF guidelines. Learn European and Australian best practice recommendations and apply your knowledge to illustrative case studies.
Thursday 9 August
Abbott Breakfast Seminar Stryker Breakfast Seminar

All you need to know about PFO in 2018

PFO Closure: Addressing the unmet need for reducing the risk of recurrent ischemic stroke

Date: Thursday 9 August
Time: 0745-0845
Room: C2.2 & C2.3, Level 2, ICC
Cost: Included for all full conference delegates and Thursday day-only delegates
Speakers: 

Description: Become familiar with the recently published data on PFO closure for stroke risk reduction, and what this means for patients and practice. Understand the importance of the heart-brain team for comprehensive stroke workup and patient selection for PFO closure.

THIS BREAKFAST IS FULL – please email [email protected] if you would like to be added to the waiting list.

Advantages and disadvantages of Direct Thrombectomy

Date: Thursday 9 August
Time: 0745 – 0845
Room: C2.5, Level 2, ICC
Cost: Included for full conference delegates and Thursday day-only delegates

Speakers
Description: The current standard therapy for acute ischemic stroke with large vessel occlusion is combined intravenous thrombolysis (IVT) with endovascular clot retrieval (ECR). However, there remains uncertainty regarding the necessity of intravenous thrombolysis in this group of patients. Recent clinical registries showed no additional benefits in outcomes comparing combined IVT + ECR with direct ECR and in addition, there are concerns that patients who harbour intracranial atherosclerotic disease may have increased symptomatic haemorrhage in the setting of exposure to IVT and anti-platelets. The current uncertainty on this question necessitates answers from randomized controlled studies. We present here an outline of DIRECT-SAFE, an international, multi-centre, randomized controlled study which examines the difference in clinical outcomes between direct ECR and standard combined IVT + ECR.
Boehringer Ingelheim Sponsored Symposium

SIMULATION
Date: Thursday 9 August
Time: 1330 – 1500
Room: C2.3, Level 2, ICC
Cost: Included for all full conference delegates and Thursday day-only delegates
Speakers: 
  • Ian Summers
  • Lauren Sanders
Description: A practical introduction to using simulation training to improve hyperacute stroke care. The symposium will include simulation demonstrations and cover key elements of running off-site and in situ simulation, scenario development and debriefing structure.
Friday 10 August
Allergan Breakfast Seminar Amgen Breakfast Seminar

THE EVIDENCE FOR EARLY TREATMENT OF SPASTICITY AND LONG TERM CONSEQUENCES OF STROKE
Date: Friday 10 August
Time: 0745-0845
Room: C2.2 & C2.3, Level 2, ICC
Cost: Included for all full conference delegates and Friday day-only delegates
Speakers: 

Description: After stroke individuals experience persisting physical, cognitive, language and/or psychological sequelae. These are often debilitating for patients with a third feeling unprepared to manage the associated disability.

Read more

The adaptive capacity of the brain post stroke known as neuronal plasticity is ‘the mechanism by which the brain encodes experience and learns new behaviour’. In rehabilitation, to harness neuroplasticity, therapies focus on task-specific repetition. The tasks must however be sufficiently challenging, meaningful, repetitive and intensive in order to promote motor re-learning.

The benefits of early intervention post stroke will be highlighted from recent evidence relating to the treatment of spasticity. This paper will report the prevalence of spasticity at 3-12 months post stroke. Specific risk factors predictive of post stroke spasticity and the value of early intervention with botulinum toxin will be outlined.

Recording long-term functional outcomes after stroke can identify other factors which may be addressed in early treatment. The Post Stroke Checklist (PSC) (endorsed by the World Stroke Organization and incorporated into the Canadian Stroke Best Practice Recommendations) identifies common long-term deficits after stroke with suggestions for referral for treatment. An Australian study and a concurrently run Chinese study have utilised the checklist to record ongoing problems at 6 months post stroke. Of the sample (n=210), 82.4% reported at least one deficit at 6 months and on average patients experienced between 3 – 6 problems post stroke. The most common problems areas related to changes in life, cognition, activities of daily living, mobility, mood and spasticity. The paper will contrast these results with studies from Great Britain, Singapore and Italy

Read less

THIS BREAKFAST IS FULL – please email [email protected] if you would like to be added to the waiting list.

PCSK9 inhibitors- New Horizon in lipid control?

Date: Friday 10 August
Time: 0745 – 0845
Room: C2.5, Level 2, ICC
Cost: Included for full conference delegates and Friday day-only delegates

Speaker:
Description: Clinical studies have demonstrated the association between elevated LDL-C and stroke, and current dyslipidaemia guidelines recommend LDL-C lowering to reduce CVD risk. However, many patients are unable to achieve LDL-C goals, and residual risk remains despite treatment with statins ± ezetimibe. The availability of PCSK9 inhibitors heralds a new paradigm in lipid control.